Ergomed PLC | Ownership

Companies that own Ergomed PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Slater Investments Ltd.
4,469,000
9.96%
0
1.12%
05/01/2018
Octopus Investments Ltd.
3,052,289
6.8%
-92,335
0.3%
04/06/2018
GVQ Investment Management Ltd.
2,704,250
6.03%
2,704,250
0.78%
08/15/2018
BlackRock Investment Management (UK) Ltd.
2,244,359
5%
844,359
0%
05/23/2018
Harwood Capital LLP
1,740,000
3.88%
0
0.59%
02/01/2018
Rathbone Investment Management Ltd.
1,558,000
3.47%
82,000
0.02%
06/01/2018
Cavendish Asset Management Ltd.
984,400
2.19%
0
0.17%
07/31/2018
Aramea Asset Management AG
325,000
0.72%
0
0.19%
09/30/2017
Hargreaves Lansdown Stockbrokers Ltd.
283,000
0.63%
62,000
0%
06/01/2018
Astor Investment Advisors SIM SpA
202,407
0.45%
-29,537
2.58%
06/29/2018

About Ergomed

View Profile
Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://ergomedplc.com/
Updated 07/08/2019
Ergomed Plc is a clinical development company. The company is engaged in the provision of services to the pharmaceutical industry and the development of orphan drugs. It focuses on the development of oncology, neurology and immunology drugs.